Sherief Abd-Elsalam
Tanta, 35111, Egypt
Location status: Recruiting
Location contact
Fedaa Kotkata, Msc
CONTACT
NCT Number: NCT03770923
Effect of Some Drugs on Rheumatoid Arithritis Activity.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Phase 3
Tanta, 35111, Egypt
Location status: Recruiting
Fedaa Kotkata, Msc
CONTACT
The study aims at evaluating the effect of Some Drugs on Rheumatoid Arithritis Activity.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Rupatadine 10 mg daily
Montelukast 10 mg daily
Time frame: 6 months
change in level of IL-17
Contact information is provided by the study sponsor or research team.
Sherief Abd-Elsalam
Other
Clinical Study Evaluating the Effect of Histamine 1 Receptor Antagonist and Leukotreine Receptor Antagonist on Patients With Rheumatoid Arithritis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07363590
Arthritis, Arthritis, Rheumatoid
Southport, Queensland, Australia
View Trial DetailsNCT03816345
Arthritis, Arthritis, Psoriatic
Birmingham, Alabama, United States
View Trial DetailsNCT07207954
Arthritis, Arthritis, Rheumatoid
Melbourne, Australia
View Trial DetailsNCT07295847
Arthritis, Arthritis, Rheumatoid
Tucson, Arizona, United States
View Trial Details